Suchergebnisse - "Tavakolpour, Soheil"

PubPharm (150)

21

COVID-19-associated mucormycosis in Iran: A retrospective study on 52 patients

enthalten in: ResearchSquare.com | 2022

von Tavakolpour, S. | Irani, S. | Yekaninejad, M. | +13

22

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment : a case series of 13 patients

enthalten in: The Journal of dermatological treatment | 2022

von Kianfar, N. | Dasdar, S. | Mahmoudi, H. | +3

23

Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia : a randomized controlled trial

enthalten in: The Journal of dermatological treatment | 2022

von Mahmoudi, H. | Rostami, A. | Tavakolpour, S. | +6

24

Evaluating the risk-to-benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab : A retrospective study with 494 patients

enthalten in: Dermatologic therapy | 2022

von Faraji, H. | Daneshpazhooh, M. | Ehsani, A. | +6

25

Punctate Pattern and Pemphigus : Is There Any Evidence of Punctate Pattern Among Iranian Patients?

enthalten in: The American Journal of dermatopathology | 2022

von Esmaili, N. | Kamyab, K. | Hatami, P. | +6

26

Editorial : Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond

enthalten in: Frontiers in medicine | 2022

von Mahmoudi, H. | Patsatsi, A. | Murrell, D. | +2

27

Pustular eruption after biosimilar rituximab infusion : report of acute generalized exanthematous pustulosis in two patients with pemphigus

enthalten in: International journal of dermatology | 2022

von Daneshpazhooh, M. | Tavakolpour, S. | Salehi Farid, A. | +4

28

Immunological aspects of COVID‐19‐related skin manifestations : Revisiting pathogenic mechanism in the light of new evidence

enthalten in: Dermatologic Therapy | 2022

von Mahdiabadi, S. | Rajabi, F. | Tavakolpour, S. | +1

29

Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients : New evidence for the safety of rituximab

enthalten in: Dermatologic Therapy | 2022

von Aryanian, Z. | Tahooneban, A. | Balighi, K. | +6

30

Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab : A retrospective study with 494 patients

enthalten in: Dermatologic Therapy | 2022

von Faraji, H. | Daneshpazhooh, M. | Ehsani, A. | +6